Dr. Patrick B. Callaghan, DO

Dr. Callaghan practices at Allentown Campus - Interventional Radiology Unit - HOPD in Allentown, Pennsylvania.

Dr. Callaghan's NPI, 1225563489, was assigned on April 25, 2017. Dr. Callaghan graduated from Philadelphia College of Osteopathic Medicine in 2017. Dr. Callaghan holds Pennsylvania license OT017687.

Dr. Callaghan's primary practice is Allentown Campus - Interventional Radiology Unit - HOPD, at 1736 Hamilton St, Allentown, PA 18104.

Dr. Callaghan's primary practice is Allentown Campus - Interventional Radiology Unit - HOPD in Allentown, Pennsylvania. Dr. Callaghan is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Callaghan to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Callaghan practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Callaghan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Callaghan is licensed in Pennsylvania.

CMS data shows 703 Medicare services from Dr. Callaghan across 7 procedure codes in 2024, for 298 Medicare patients. Medicare paid $58,079 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 298 Medicare patients who saw Dr. Callaghan in 2024. The largest group is 75 to 84, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Callaghan's median patient age at 73, with 53% women.

In 2024, Dr. Callaghan wrote 301 Medicare Part D claims for 136 patients. 88% of them were for generic drugs. CMS names the drug for 113 of them, across 8 drugs with 11 or more claims each, at $10,355 in total drug cost. In 2023, CMS named 75 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Callaghan for performance year 2024, reported through an alternative payment model (APM). Dr. Callaghan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 47 papers to Dr. Callaghan, published from 2009 to 2025. 2015 was the busiest year, with 6. The most frequent topics are United Kingdom, Mental Disorders and Mental Health Services. Dr. Callaghan has published most often in J Psychiatr Ment Health Nurs. Dr. Callaghan's most frequent co-authors are Vishal Aggarwal, MD, Anirban Banerjee, MD and Nicholas James Evans, MD.

CMS Open Payments shows 14 general payments to Dr. Callaghan from 5 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,058.

Dr. Callaghan graduated from Philadelphia College of Osteopathic Medicine in 2017.